AmorePacific Corp
KRX:090430
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
107 000
194 200
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
AmorePacific Corp
Operating Income
AmorePacific Corp
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
AmorePacific Corp
KRX:090430
|
Operating Income
â‚©114.8B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-13%
|
||
Amorepacific Group
KRX:002790
|
Operating Income
â‚©200.1B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-11%
|
||
Cosmax Inc
KRX:192820
|
Operating Income
â‚©157.6B
|
CAGR 3-Years
15%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
||
LG H&H Co Ltd
KRX:051900
|
Operating Income
â‚©335.9B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-4%
|
||
Kolmar Korea Co Ltd
KRX:161890
|
Operating Income
â‚©196.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
11%
|
CAGR 10-Years
17%
|
||
H
|
Hyundai Bioscience Co Ltd
KOSDAQ:048410
|
Operating Income
-â‚©8.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-4%
|
AmorePacific Corp
Glance View
Amorepacific Corp. engages in the research, development, and marketing of beauty and health products. The company is headquartered in Seoul, Seoul. The company went IPO on 2006-06-29. The firm operates its business through two segments. The Cosmetic segment is mainly engaged in the manufacture and distribution of skin care products, makeup products and perfumes under the brand names of Sulwhasoo, Hera, IOPE, Laneige, MAMONDE, Haneul, Odyssey and others. The Daily Beauty (DB) and Sulloc segment is mainly engaged in the manufacture and distribution of shampoos, body cleansers and toothpastes under the brand names of Mise en Scene, Happy Bath, Ryoe, Dantrol and Median. This segment also manufactures and sells green tea products under the brand name of O'Sulloc. The firm distributes its cosmetic products through discount stores, specialty stores, department stores, online shopping malls and others, as well as to overseas markets.
See Also
What is AmorePacific Corp's Operating Income?
Operating Income
114.8B
KRW
Based on the financial report for Jun 30, 2024, AmorePacific Corp's Operating Income amounts to 114.8B KRW.
What is AmorePacific Corp's Operating Income growth rate?
Operating Income CAGR 10Y
-13%
Over the last year, the Operating Income growth was -21%. The average annual Operating Income growth rates for AmorePacific Corp have been -29% over the past three years , -21% over the past five years , and -13% over the past ten years .